https://www.selleckchem.com/products/art558.html
Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been widely used in adults with Type 2 diabetes (T2D) and obesity. We sought to evaluate the experience of pediatric endocrinology providers with GLP-1RA and factors that guide them on whether and how to prescribe these medications. We surveyed the members of the Pediatric Endocrine Society regarding the use of GLP-1RA in their practice. The respondents (n= 102) were predominantly from academic centers (84%) and 75%reported using GLP-1RA in pediatric patients, mostly to treat T2D a
Like
Comment
Share
